Comb-Insulin S

Comb-Insulin C: An innovative solution for controlling blood sugar levels

In the modern world, diabetes is becoming an increasingly common disease that requires constant monitoring and control. People suffering from diabetes must take insulin regularly to maintain normal blood sugar levels. In this context, drug innovation plays an important role. One of the latest advances in the field of diabetes treatment is Comb-Insulin S.

Comb-Insulin C belongs to the group of insulins with a combined duration of action and is produced in Germany by Hoechst AG. This drug is an injection suspension containing 40 IU/ml insulin. It is an international analogue of insulin-comb.

Comb-Insulin C offers diabetic patients an effective and convenient way to control their blood sugar levels. It combines the benefits of different drugs with different durations of action of insulin, which allows you to achieve more precise regulation of glucose in the body.

Synonyms of Comb-Insulin C include Actrafan HM penfil 100, Berlinsulin N 10/90 U-40, Berlinsulin N 10/90 pen, Berlinsulin N 20/80 U-40, Berlinsulin N 20/80 pen, Berlinsulin N 30/70 U- 40, Berlinsulin N 30/70 pen, Berlinsulin N 40/60 U-40, Berlinsulin N 40/60 pen, Biogulin 30/70 U-100 and Insul.

The main advantage of Comb-Insulin C is its ability to provide stable sugar levels for a long time. This allows diabetic patients to have more flexibility in managing their insulin regimen and reduce the number of injections throughout the day.

Comb-Insulin C was developed taking into account modern technologies and scientific achievements in the field of diabetes treatment. It is the result of many years of research and clinical trials that guarantee its safety and effectiveness.

In conclusion, Comb-Insulin C is an innovative drug intended for the treatment of diabetes. It provides patients with precise control of their blood sugar levels and improves their quality of life. Thanks to its unique properties and benefits, ComComb-Insulin S: An innovative solution for controlling blood sugar levels

Comb-Insulin C, produced in Germany by Hoechst AG, is one of the newest drugs intended for the treatment of diabetes. It belongs to the group of insulins with a combined duration of action and is an injection suspension containing 40 IU/ml insulin.

The main advantage of Comb-Insulin C is its ability to provide stable blood sugar levels for a long time. This is achieved thanks to the combined composition of the drug, which combines different durations of action of insulin. This approach allows for more precise regulation of glucose levels in the body and reduces the need for frequent injections.

Comb-Insulin S has the international name "Insulin-Comb" and is also known under various synonyms, including Aktrafan HM penfil 100, Berlinsulin N 10/90 U-40, Berlinsulin N 10/90 pen, Berlinsulin N 20/80 U-40, Berlinsulin N 20/80 pen, Berlinsulin N 30/70 U-40, Berlinsulin N 30/70 pen, Berlinsulin N 40/60 U-40, Berlinsulin N 40/60 pen, Biogulin 30/70 U-100 and Insul.

The drug was developed using advanced technologies and scientific advances in the field of diabetes treatment. It has undergone many clinical trials confirming its safety and effectiveness. Comb-Insulin C represents a significant advance in the treatment of diabetes and is becoming an increasingly popular drug among patients.

In conclusion, Comb-Insulin C is an innovative solution for controlling blood sugar levels in diabetic patients. Thanks to its combined composition and duration of action, it allows you to achieve more accurate and stable glucose control. Patients using Comb-Insulin C can enjoy an improved quality of life and a more flexible insulin regimen.